Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Subject
Materials Chemistry,Industrial and Manufacturing Engineering,General Chemical Engineering,Biochemistry,General Chemistry
Reference28 articles.
1. Alexander T, Severin M, Thomas F, Michael S, Johann S, Stefan P, Walter J, Viktoria Z, Gaia N, Nicolas T, Martin B, Thomas W, Oliver L (2019) Inhibition of ABCB1 and ABCG2 at the mouse blood−brain barrier with marketed drugs to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib. Mol Pharmaceut 16:1282–1293
2. Aliabad HAR, Chahkandi M (2018) Theoretical study of crystalline network and optoelectronic properties of erlotinib hydrochloride molecule: non-covalent interactions consideration. Chem Pap. https://doi.org/10.1007/s11696-018-0607-3
3. Aljakouch K, Lechtonen T, Yosef HK, Hammoud MK, Alsaidi W, Kçtting C, Mggge C, Kourist R, El-Mashtoly SF, Gerwert K (2018) Raman microspectroscopic evidence for the metabolism of a tyrosine kinase inhibitor, neratinib, in cancer cells. Angew Chem Int Ed 57:7250–7254
4. Annapurna MM, Venkatesh B, Chaitanya RK (2014) Analytical techniques for the determination of Erlotinib HCl in pharmaceutical dosage forms by spectrophotometry. Chem Sci Trans 3:840–846
5. Bridges AJ (2001) Chemical inhibitors of protein kinases. Chem Rev 101:2541–2571